EcoDrugPlus

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSBMSG00010022088
Gene Symbol: AGER
1 Cross references
170 Possible Orthologues:

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSBMSG00010001007
Gene Symbol: ADH5
1 Cross references
405 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSBMSG00010019804
Gene Symbol: AKR1B1
1 Cross references
422 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSBMSG00010021475
Gene Symbol: GAA
1 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSBMSG00010014295
Gene Symbol: AOC1
1 Cross references
233 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSBMSG00010016258
Gene Symbol: APP
1 Cross references
279 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSBMSG00010017403
Gene Symbol: AR
1 Cross references
277 Possible Orthologues:

Angiotensin I Converting Enzyme

Ensembl ID : ENSBMSG00010016264
Gene Symbol: ACE
1 Cross references
92 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSBMSG00010000298
Gene Symbol: AGTR1
1 Cross references
214 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSBMSG00010021033
Gene Symbol: AGTR2
1 Cross references
195 Possible Orthologues:

Apelin Receptor

Ensembl ID : ENSBMSG00010005859
Gene Symbol: APLNR
1 Cross references
172 Possible Orthologues:

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSBMSG00010000650
Gene Symbol: APH1B
1 Cross references
192 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).